These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25014449)

  • 1. [Decreasing dynamin 2 to rescue myotubular myopathy].
    Laporte J; Cowling B
    Med Sci (Paris); 2014; 30(6-7):621-4. PubMed ID: 25014449
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical utility gene card for: Centronuclear and myotubular myopathies.
    Biancalana V; Beggs AH; Das S; Jungbluth H; Kress W; Nishino I; North K; Romero NB; Laporte J
    Eur J Hum Genet; 2012 Oct; 20(10):. PubMed ID: 22617344
    [No Abstract]   [Full Text] [Related]  

  • 3. Tamoxifen therapy in a murine model of myotubular myopathy.
    Maani N; Sabha N; Rezai K; Ramani A; Groom L; Eltayeb N; Mavandadnejad F; Pang A; Russo G; Brudno M; Haucke V; Dirksen RT; Dowling JJ
    Nat Commun; 2018 Nov; 9(1):4849. PubMed ID: 30451841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing dynamin 2 (DNM2) rescues
    Buono S; Ross JA; Tasfaout H; Levy Y; Kretz C; Tayefeh L; Matson J; Guo S; Kessler P; Monia BP; Bitoun M; Ochala J; Laporte J; Cowling BS
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):11066-11071. PubMed ID: 30291191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice.
    Tasfaout H; Buono S; Guo S; Kretz C; Messaddeq N; Booten S; Greenlee S; Monia BP; Cowling BS; Laporte J
    Nat Commun; 2017 Jun; 8():15661. PubMed ID: 28589938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new centronuclear myopathy phenotype due to a novel dynamin 2 mutation.
    Bitoun M; Bevilacqua JA; Eymard B; Prudhon B; Fardeau M; Guicheney P; Romero NB
    Neurology; 2009 Jan; 72(1):93-5. PubMed ID: 19122038
    [No Abstract]   [Full Text] [Related]  

  • 7. Centronuclear myopathies: a widening concept.
    Romero NB
    Neuromuscul Disord; 2010 Apr; 20(4):223-8. PubMed ID: 20181480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene symbol: MTM1. Disease: Myotubular myopathy.
    Mueller OT
    Hum Genet; 2008 Jun; 123(5):539. PubMed ID: 20960609
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene symbol: MTM1. Disease: Myotubular myopathy.
    Mueller OT; Coovadia A
    Hum Genet; 2008 Oct; 124(3):297. PubMed ID: 18846617
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene symbol: MTM1. Disease: Myotubular myopathy.
    Mueller OT
    Hum Genet; 2008 Jun; 123(5):538. PubMed ID: 20960603
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene symbol: MTM1. Disease: Myotubular myopathy?
    Mueller OT; Coovadia A
    Hum Genet; 2008 Jun; 123(5):539. PubMed ID: 20960607
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic testing for myotubular myopathy despite muscle biopsy without centrally located nuclei.
    Foye PM
    Dev Med Child Neurol; 2006 Dec; 48(12):1011. PubMed ID: 17109798
    [No Abstract]   [Full Text] [Related]  

  • 13. Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy.
    Gayi E; Neff LA; Massana Muñoz X; Ismail HM; Sierra M; Mercier T; Décosterd LA; Laporte J; Cowling BS; Dorchies OM; Scapozza L
    Nat Commun; 2018 Nov; 9(1):4848. PubMed ID: 30451843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some DNM2 mutations cause extremely severe congenital myopathy and phenocopy myotubular myopathy.
    Biancalana V; Romero NB; Thuestad IJ; Ignatius J; Kataja J; Gardberg M; Héron D; Malfatti E; Oldfors A; Laporte J
    Acta Neuropathol Commun; 2018 Sep; 6(1):93. PubMed ID: 30208955
    [No Abstract]   [Full Text] [Related]  

  • 15. Muscle imaging in congenital myopathies.
    Quijano-Roy S; Carlier RY; Fischer D
    Semin Pediatr Neurol; 2011 Dec; 18(4):221-9. PubMed ID: 22172417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital myotubular myopathy with a novel MTM1 gene mutation in a premature infant presenting with ventilator dependency and intrahepatic cholestasis.
    Lee IC; Su PH; Chen JY; Hu JM; Lu JJ; Ng YY
    J Child Neurol; 2012 Jan; 27(1):99-104. PubMed ID: 21881007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial alterations in dynamin 2-related centronuclear myopathy.
    Zanoteli E; Vergani N; Campos Y; Vainzof M; Oliveira AS; d'Azzo A
    Arq Neuropsiquiatr; 2009 Mar; 67(1):102-4. PubMed ID: 19330221
    [No Abstract]   [Full Text] [Related]  

  • 18. Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset.
    Melberg A; Kretz C; Kalimo H; Wallgren-Pettersson C; Toussaint A; Böhm J; Stålberg E; Laporte J
    Neuromuscul Disord; 2010 Jan; 20(1):53-6. PubMed ID: 19932619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle biopsy without centrally located nuclei in a male child with mild X-linked myotubular myopathy.
    de Goede CG; Kelsey A; Kingston H; Tomlin PI; Hughes MI
    Dev Med Child Neurol; 2005 Dec; 47(12):835-7. PubMed ID: 16288675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibres due to a DNM2 mutation.
    Romero NB; Bevilacqua JA; Oldfors A; Fardeau M
    Neuromuscul Disord; 2011 Feb; 21(2):148; author reply 148-9. PubMed ID: 21247764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.